Two Sigma Advisers LP Sells 56,100 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Two Sigma Advisers LP reduced its stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 13.2% during the fourth quarter, HoldingsChannel reports. The firm owned 369,476 shares of the company’s stock after selling 56,100 shares during the period. Two Sigma Advisers LP’s holdings in Crescent Capital BDC were worth $7,101,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Franklin Resources Inc. raised its position in shares of Crescent Capital BDC by 12.8% during the 4th quarter. Franklin Resources Inc. now owns 289,131 shares of the company’s stock valued at $5,557,000 after buying an additional 32,852 shares in the last quarter. Condor Capital Management grew its position in Crescent Capital BDC by 4.7% in the fourth quarter. Condor Capital Management now owns 284,055 shares of the company’s stock worth $5,460,000 after acquiring an additional 12,852 shares in the last quarter. Wells Fargo & Company MN increased its stake in Crescent Capital BDC by 0.5% in the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company’s stock valued at $4,866,000 after acquiring an additional 1,210 shares during the last quarter. Raymond James Financial Inc. bought a new position in Crescent Capital BDC in the fourth quarter valued at $3,750,000. Finally, Denali Advisors LLC raised its position in Crescent Capital BDC by 0.5% during the fourth quarter. Denali Advisors LLC now owns 183,783 shares of the company’s stock valued at $3,532,000 after purchasing an additional 855 shares in the last quarter. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Stock Up 0.4%

Shares of NASDAQ:CCAP opened at $15.39 on Friday. The stock has a market capitalization of $570.35 million, a P/E ratio of 7.73 and a beta of 0.63. The stock’s 50-day moving average price is $16.02 and its 200-day moving average price is $17.99. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. Crescent Capital BDC, Inc. has a 12-month low of $13.54 and a 12-month high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last issued its earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The company had revenue of $42.13 million for the quarter, compared to analysts’ expectations of $45.08 million. On average, equities analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 10.92%. The ex-dividend date of this dividend is Monday, June 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 125.37%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Wall Street Zen cut Crescent Capital BDC from a “hold” rating to a “sell” rating in a report on Thursday. Raymond James dropped their target price on Crescent Capital BDC from $20.00 to $17.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Keefe, Bruyette & Woods lowered Crescent Capital BDC from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $18.50 to $17.00 in a research note on Friday, May 16th. Finally, Wells Fargo & Company decreased their price target on shares of Crescent Capital BDC from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Friday, May 16th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $17.60.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.